Genelux prices $20M public offering of 6.7M shares at $3.00

GENELUX Corp

Priced underwritten public offering of 6,666,667 shares at $3.00 each.
Gross proceeds of approx. $20M before underwriting discounts and expenses.
Underwriter granted 30-day option to buy up to 1,000,000 additional shares.
Proceeds for general corporate purposes including R&D, clinical trials, and working capital.
Offering expected to close January 9, 2026; sole book-runner Lucid Capital Markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.